Episode Details
Back to Episodes
Pharmaceutical Executive Daily: New Research Suggests Ozempic May Reduce Biological Age
Published 6 months, 3 weeks ago
Description
In today’s Pharmaceutical Executive Daily, we cover the FDA approval of Bayer’s Lynkuet for menopausal hot flashes, new research suggesting Ozempic may reduce biological age, and Novartis’ $12 billion merger agreement to acquire Avidity Biosciences.